Icon of the Instituts for Quality and Efficiency in Health Care

Report

Ginkgo compounds in Alzheimer's disease

Status
Status: Commission completed
Project no.
A05-19B
Last updated

Report documents

  1. Executive summary of the final report

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 48 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 48 kB, EN, not accessible)

  2. Final report

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    Download file : Final report (PDF document, 1 MB, DE, not accessible)

  3. Documentation and appraisal of comments on the preliminary report version 2.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 766 kB, DE, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report version 2.0 (PDF document, 766 kB, DE, not accessible)

  4. Preliminary report version 2.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    Download file : Preliminary report version 2.0 (PDF document, 1 MB, DE, not accessible)

  5. Report plan version 2.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 248 kB, DE, not accessible
    Download file : Report plan version 2.0 (PDF document, 248 kB, DE, not accessible)

  6. Documentation and appraisal of comments on the report plan version 1.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 5 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the report plan version 1.0 (PDF document, 5 MB, DE, not accessible)

  7. Preliminary report version 1.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 584 kB, DE, not accessible
    Download file : Preliminary report version 1.0 (PDF document, 584 kB, DE, not accessible)

  8. Amendment 1 to the report plan version 1.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 37 kB, DE, not accessible
    Download file : Amendment 1 to the report plan version 1.0 (PDF document, 37 kB, DE, not accessible)

  9. Report plan version 1.0

    Ginkgo compounds in Alzheimer's disease

    published on
    Document type
    PDF document, 88 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 88 kB, DE, not accessible)

Press releases

Alzheimer’s disease: only a few therapies provide proof of benefit to patients

Cholinesterase inhibitors and ginkgo may alleviate some symptoms – Non-drug approaches are insufficiently investigated – Marked increase in supporting research
Press release

Ginkgo biloba in Alzheimer's disease: evidence from studies is mixed

With high-dose Ginkgo, patients cope better with daily activities / Studies from Eastern Europe showing particularly positive effects dominate the assessment
Press release

Additional information

IQWiG health information

Do Ginkgo products help?

Project details

Project no.
A05-19B
Commission
Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Head and nerves

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page